University of Connecticut

Events Calendar

UConn Dermatology Grand Rounds

Wednesday, August 1, 2018
8:00am – 12:00pm

UConn Health
21 South Road, 2nd Floor, Farmington


“Creative Therapies in Dermatology”

Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and the Department of Dermatology

Speaker: Jacob Levitt, MD – Professor, Department of Dermatology, Mount Sinai, NYC, NY. Date: Wednesday, August 1, 2018 Time: Lecture: 8am – 9:30am, Patient viewing: 9:30am - 12pm Location: University of Connecticut Health Center, Dermatology Department, 21 South Road, 2nd Floor, Conference Room

Target Audience: UCHC dermatologists and dermatology residents. All other podiatrists, nurses, nurse practitioners, residents, students, and greater Hartford dermatologists are encouraged to attend.

Objectives: Participants will (be able to):

a. Recite the evidence or expert opinion associated with the treatment of warts, perforating collegenosis, keratoacanthoma, subacute cutaneous lupus erythematosus, herpes associated erythema multiforme, pyogenic granuloma, pretibial myxedema, and pemphigus vulgaris. b. Barriers to implementing the evidence or expert opinion in the lack of insurance coverage or FDA-labelled indications for the treatments discussed. c. To implement the evidence/expert opinion or overcome any barrier to implementation we will utilize a case-based interactive discussion to recognize and treat dermatoses refractory to first line therapy.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Connecticut School of Medicine designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Dr. Levitt has a financial interest/arrangement with Genentech (Ad Board –Rituxan 2017), Amgen (Enbrel – 2016) and AbbVie (Humira – 2018) that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. The following safeguards have been put in place to avoid the insertion of commercial bias into the content: The activity director peer-reviewed the content of the presentation and will restrict the speaker’s presentation to areas outside the area of conflict to ensure that no commercial bias exists.

Dr. Levitt will be discussing the off-labeled use of the following products: Enbrel; Otezla;


Christina Iwanik - - 860-679-6759

Continuing Medical Education (primary), UConn Master Calendar

Control Panel